Bortezomib and Topotecan Hydrochloride in Treating Patients With Advanced Solid Tumors

NCT00541359 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: bortezomib
DRUG: topotecan hydrochloride
OTHER: immunohistochemistry staining method
OTHER: pharmacological study

Sponsor

City of Hope Medical Center